Cesar A Keller1, Thomas A Gonwa1, Launia J White2, March E Rucci2, Sue L Visscher2, Cassie C Kennedy2,3, Richard C Daly4, James M Naessens2,5. 1. Department of Transplantation, Mayo Clinic, Jacksonville, FL. 2. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota and Jacksonville, FL. 3. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN. 4. Division of Cardiovascular Surgery, Department of Surgery, Mayo Clinic, Rochester, MN. 5. Division of Health Care Policy & Research, Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
Abstract
BACKGROUND: Lungs are allocated in the United States using the lung allocation score (LAS). We investigated the effect of LAS trends on lung transplant-related costs, healthcare utilization, and mortality. METHODS: Utilization data from Mayo Clinic (Florida and Minnesota) from 2005 to 2015 were obtained from the electronic health records (N = 465). Costs were categorized as 1-year posttransplant or transplant episode and standardized using 2015 Medicare reimbursement and cost-to-charge ratios. Regression analysis was used to assess the relationship of LAS to length of stay (LOS), mortality, and cost of transplant. RESULTS: The mean LAS at transplant increased from 45.7 to 58.3 during the study period, whereas the 1-year survival improved from 88.1% to 92.5% (P < 0.0001). The proportion of patients transplanted with LAS of 60 or greater increased from 16.9% to 33.3%. Posttransplant, overall, and intensive care unit LOS increased with increasing LAS. Patients with higher LAS had substantially higher transplant episode costs. An increase of LAS at transplant by 10 points increased inflation-adjusted costs by 12.0% (95% confidence interval, 9.3%-14.5%). CONCLUSIONS: The mean LAS at transplant has significantly increased over time associated with increases in LOS, resource utilization and cost. Lung allocation score has not jeopardized overall survival, but a high LAS (>60) at transplant is associated with increased mortality.
BACKGROUND: Lungs are allocated in the United States using the lung allocation score (LAS). We investigated the effect of LAS trends on lung transplant-related costs, healthcare utilization, and mortality. METHODS: Utilization data from Mayo Clinic (Florida and Minnesota) from 2005 to 2015 were obtained from the electronic health records (N = 465). Costs were categorized as 1-year posttransplant or transplant episode and standardized using 2015 Medicare reimbursement and cost-to-charge ratios. Regression analysis was used to assess the relationship of LAS to length of stay (LOS), mortality, and cost of transplant. RESULTS: The mean LAS at transplant increased from 45.7 to 58.3 during the study period, whereas the 1-year survival improved from 88.1% to 92.5% (P < 0.0001). The proportion of patients transplanted with LAS of 60 or greater increased from 16.9% to 33.3%. Posttransplant, overall, and intensive care unit LOS increased with increasing LAS. Patients with higher LAS had substantially higher transplant episode costs. An increase of LAS at transplant by 10 points increased inflation-adjusted costs by 12.0% (95% confidence interval, 9.3%-14.5%). CONCLUSIONS: The mean LAS at transplant has significantly increased over time associated with increases in LOS, resource utilization and cost. Lung allocation score has not jeopardized overall survival, but a high LAS (>60) at transplant is associated with increased mortality.
Authors: Bryan G Maxwell; Joshua J Mooney; Peter H U Lee; Joseph E Levitt; Laveena Chhatwani; Mark R Nicolls; Martin R Zamora; Vincent Valentine; David Weill; Gundeep S Dhillon Journal: Am J Respir Crit Care Med Date: 2015-02-01 Impact factor: 21.405
Authors: Gabriel Loor; David M Radosevich; Rosemary F Kelly; Irena Cich; Timothy S Grabowski; Christopher Lyon; J Michael Morrow; Edward M Bender; Joanne Billings; Marshall Hertz Journal: Ann Thorac Surg Date: 2016-08-01 Impact factor: 4.330
Authors: T M Egan; S Murray; R T Bustami; T H Shearon; K P McCullough; L B Edwards; M A Coke; E R Garrity; S C Sweet; D A Heiney; F L Grover Journal: Am J Transplant Date: 2006 Impact factor: 8.086
Authors: Cynthia J Gries; Michael S Mulligan; Jeffrey D Edelman; Ganesh Raghu; J Randall Curtis; Christopher H Goss Journal: Chest Date: 2007-12 Impact factor: 9.410
Authors: Wayne M Tsuang; David M Vock; C Ashley Finlen Copeland; David J Lederer; Scott M Palmer Journal: Ann Intern Med Date: 2013-05-07 Impact factor: 25.391
Authors: Sue L Visscher; James M Naessens; Barbara P Yawn; Megan S Reinalda; Stephanie S Anderson; Bijan J Borah Journal: BMC Health Serv Res Date: 2017-06-12 Impact factor: 2.655
Authors: William F Parker; Nicole E Dussault; Renea Jablonski; Edward R Garrity; Matthew M Churpek Journal: J Heart Lung Transplant Date: 2021-10-28 Impact factor: 13.569
Authors: Luiza Helena Degani-Costa; João Paulo de Assis; Pedro Paulo Pisaniello Gonçalves; Fernanda Gushken; Gilberto Szarf; José Eduardo Afonso Junior Journal: Einstein (Sao Paulo) Date: 2021-12-20
Authors: Darya Rudym; Luke Benvenuto; Joseph Costa; Meghan Aversa; Hilary Robbins; Lori Shah; Hanyoung Kim; Bryan P Stanifer; Joshua Sonett; Frank D'Ovidio; Selim M Arcasoy Journal: Ann Transplant Date: 2020-08-18 Impact factor: 1.530